Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

Hiển thị phiên bản (1) khác

Background For women with oestrogen receptor (ER)-positive early breast cancer, treatment with tamoxifen for 5 years substantially reduces the breast cancer mortality rate throughout the first 15 years after diagnosis. We aimed to assess the further effects of continuing tamoxifen to 10 years instea...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Davies, C, Pan, H, Gray, R, Collins, R, Delmestri, A, Wang, Y, Peto, R, Godwin, J, Arriagada, R, Raina, V, Abraham, M, Medeiros Alencar, V, Badran, A, Khaled, H, Bonfill, X, Tort, S, Urrútia, G, Bradbury, J, Davis, SR, Clarke, M, Forbes, J, Haddad, P, Hou, M, Inbar, M, Kielanowska, J
Định dạng:	Journal article
Được phát hành:	2013

Những quyển sách tương tự

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Bằng: Davies, C, et al.
Được phát hành: (2013)

Five years of tamoxifen--or more?
Bằng: Peto, R
Được phát hành: (1996)

Repurposing the Selective Oestrogen Receptor Modulator Tamoxifen for the Treatment of Duchenne Muscular Dystrophy
Bằng: Elinam Gayi, et al.
Được phát hành: (2018-04-01)

10 vs 5 years of adjuvant tamoxifen: exclusion of 1/402 centres in ATLAS
Bằng: Davies, C, et al.
Được phát hành: (2017)

Tamoxifen-induced epigenetic silencing of oestrogen-regulated genes in anti-hormone resistant breast cancer.
Bằng: Andrew Stone, et al.
Được phát hành: (2012-01-01)

Aromatase Inhibitors (AIs) Versus Not (Placebo/Observation) as Late Extended Adjuvant Therapy for Postmenopausal Women with Early Stage Breast Cancer (BC): Overviews of Randomized Trials of AIs after similar to 5 Years of Tamoxifen
Bằng: Goss, P, et al.
Được phát hành: (2009)

Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen
Bằng: Dowsett, M, et al.
Được phát hành: (2009)

20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years
Bằng: Pan, H, et al.
Được phát hành: (2017)

Structural aspects of agonism and antagonism in the oestrogen receptor.
Bằng: Pike, A, et al.
Được phát hành: (2000)

Overall and subgroup findings of the aTTom trial: A randomised comparison of continuing adjuvant tamoxifen to 10 years compared to stopping after 5 years in 6953 women with ER positive or ER untested early breast cancer
Bằng: Rea, D, et al.
Được phát hành: (2013)

Variation in use of adjuvant tamoxifen.
Bằng: Davies, C, et al.
Được phát hành: (1998)

Multiple Routes to Oestrogen Antagonism
Bằng: Hilary R. Glover, et al.
Được phát hành: (2010-10-01)

Addition of Adjuvant Tamoxifen to Cyclophosphamide, Methotrexate and 5-Fluorouracil for Premenopausal Women with Oestrogen Receptor-Positive Breast Cancer
Bằng: He-Cheng Li, et al.
Được phát hành: (2003-07-01)

Oestrogens, brain function and neuropsychiatric disorders
Bằng: Craig, M, et al.
Được phát hành: (2004)

Influence of the anti‐oestrogens tamoxifen and letrozole on thyroid function in women with early and advanced breast cancer: A systematic review
Bằng: Djordje Marina, et al.
Được phát hành: (2023-01-01)

Structural insights into the mechanisms of agonism and antagonism in oestrogen receptor isoforms.
Bằng: Hubbard, R, et al.
Được phát hành: (2000)

Early breast cancer: How long should tamoxifen continue?
Bằng: Davies, C, et al.
Được phát hành: (1999)

Oestrogen: brain ageing, cognition and neuropsychiatric disorder.
Bằng: Norbury, R, et al.
Được phát hành: (2004)

[Duration of adjuvant treatment with tamoxifen in patients with resectable breast cancer]
Bằng: Davies, C, et al.
Được phát hành: (1998)

Tamoxifen therapy for patients with breast cancer - Authors' reply.
Bằng: Davies, C, et al.
Được phát hành: (2013)

Molecular basis of agonism and antagonism in the oestrogen receptor.
Bằng: Brzozowski, A, et al.
Được phát hành: (1997)

Structure and mechanism of the oestrogen receptor
Bằng: Kong, E, et al.
Được phát hành: (2003)

Structure and mechanism of the oestrogen receptor.
Bằng: Kong, E, et al.
Được phát hành: (2003)

17β-Hydroxysteroid dehydrogenase type 14 is a predictive marker for tamoxifen response in oestrogen receptor positive breast cancer.
Bằng: Tove Sivik, et al.
Được phát hành: (2012-01-01)

Oestrogen exposure and breast cancer risk.
Bằng: Travis, R, et al.
Được phát hành: (2003)

Oestrogen Receptor Positive Metastatic Eccrine Porocarcinoma: A Case Report and Review of Anti-Oestrogen Therapy in Rare Cancers
Bằng: Anita J.M. Kalakonda, et al.
Được phát hành: (2024-03-01)

The role of oestrogen and oestrogen-calcium axis in endometrial carcinoma
Bằng: Jingyi Zhou, et al.
Được phát hành: (2024-04-01)

Local Oestrogen for Pelvic Floor Disorders: A Systematic Review.
Bằng: M A Weber, et al.
Được phát hành: (2015-01-01)

Early breast cancer: How long should tamoxifen continue?
Bằng: Davies, C, et al.
Được phát hành: (1998)

RISK REDUCTION BY STOPPING SMOKING
Bằng: Beral, V, et al.
Được phát hành: (2013)

English Stop-Smoking Services: One-Year Outcomes.
Bằng: Bauld, L, et al.
Được phát hành: (2016)

Oestrogen, brain function, and neuropsychiatric disorders.
Bằng: Cutter, W, et al.
Được phát hành: (2003)

UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.
Bằng: Peto, R, et al.
Được phát hành: (2000)

Topical oestrogen keratinises the human foreskin and may help prevent HIV infection.
Bằng: Andrew J Pask, et al.
Được phát hành: (2008-01-01)

A prospective study of urinary oestrogen excretion and breast cancer risk.
Bằng: Key, T, et al.
Được phát hành: (1996)

The role of oestrogen therapy in reducing risk of Alzheimer's disease: systematic review
Bằng: Gary R. M. Wong, et al.
Được phát hành: (2023-11-01)

Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation
Bằng: Pascal Gellert, et al.
Được phát hành: (2016-11-01)

Modulation of immune functions by oestrogens. Part I
Bằng: Jacek R. Wilczyński
Được phát hành: (2010-04-01)

Modulation of immune functions by oestrogens. Part II
Bằng: Jacek R. Wilczyński
Được phát hành: (2010-06-01)

The relationships of SHBG with current and previous use of oral contraceptives and oestrogen replacement therapy.
Bằng: Key, T, et al.
Được phát hành: (1989)